{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:17Z","timestamp":1792783277884,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Austin Health","id":[{"id":"https:\/\/ror.org\/05dbj6g52","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05234-w","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:44:21Z","timestamp":1781117061000},"page":"4791-4798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative analysis of variant histology and urothelial bladder cancer following radical cystectomy"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8558-7028","authenticated-orcid":false,"given":"Thomas","family":"McMaster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6072-6191","authenticated-orcid":false,"given":"David","family":"Homewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Attwell-Heap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Perry-Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekhar","family":"Perumalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"10061","key":"5234_CR1","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m P-U, Choi W et al (2016) Bladder cancer. Lancet 388(10061):2796\u20132810","journal-title":"Lancet"},{"issue":"1","key":"5234_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clgc.2020.07.011","volume":"19","author":"M Deuker","year":"2021","unstructured":"Deuker M, Martin T, Stolzenbach F, Rosiello G, Coll\u00e0 Ruvolo C, Nocera L et al (2021) Bladder cancer: a comparison between non-urothelial variant histology and urothelial carcinoma across all stages and treatment modalities. Clin Genitourin Cancer 19(1):60\u20138.e1","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"5234_CR3","doi-asserted-by":"publisher","first-page":"161.e1","DOI":"10.1016\/j.urolonc.2024.01.009","volume":"42","author":"P Ramos","year":"2024","unstructured":"Ramos P, Mateus A, Manso M, Botelho F, Silva A, Silva J, Silva C et al (2024) Prognostic impact of variant histology in bladder cancer: Would early and aggressive treatment shift the paradigm? Urol Oncol 42(5):161.e1-.e8","journal-title":"Urol Oncol"},{"issue":"11","key":"5234_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrurol.2017.125","volume":"14","author":"M Moschini","year":"2017","unstructured":"Moschini M, D\u2019Andrea D, Korn S, Irmak Y, Soria F, Comp\u00e9rat E, Shariat SF (2017) Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol 14(11):651\u2013668","journal-title":"Nat Rev Urol"},{"issue":"7","key":"5234_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.mpdhp.2020.04.004","volume":"26","author":"E Comp\u00e9rat","year":"2020","unstructured":"Comp\u00e9rat E (2020) Pathological and molecular aspects of urothelial carcinomas. Diagn Histopathol 26(7):330\u2013336","journal-title":"Diagn Histopathol"},{"issue":"1","key":"5234_CR6","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/PAS.0000000000002077","volume":"48","author":"GP Paner","year":"2024","unstructured":"Paner GP, Kamat A, Netto GJ, Samaratunga H, Varma M, Bubendorf L et al (2024) International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and non-urothelial carcinomas. Am J Surg Pathol 48(1):e11\u2013e23","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"5234_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3892\/mco.2024.2778","volume":"21","author":"HS Lee","year":"2024","unstructured":"Lee HS, Min KS, Seo WI, Sou SJ, Chung JI, Jung SJ, Lee CH (2024) Impact of variant histology in the prognosis of non-muscle invasive bladder cancer with low-tumor burden: a propensity score-matched analysis with conventional urothelial carcinoma. Mol Clin Oncol 21(5):80","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"5234_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","volume":"6","author":"N Lobo","year":"2020","unstructured":"Lobo N, Shariat SF, Guo CC, Fernandez MI, Kassouf W, Choudhury A et al (2020) What is the significance of variant histology in urothelial carcinoma? Eur Urol Focus 6(4):653\u2013663","journal-title":"Eur Urol Focus"},{"issue":"6","key":"5234_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/JU.0000000000001305","volume":"204","author":"K Mori","year":"2020","unstructured":"Mori K, Abufaraj M, Mostafaei H, Quhal F, Karakiewicz PI, Briganti A et al (2020) A systematic review and meta-analysis of variant histology in urothelial carcinoma of the bladder treated with radical cystectomy. J Urol 204(6):1129\u20131140","journal-title":"J Urol"},{"key":"5234_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1200\/JCO.2025.43.5_suppl.744","volume":"43","author":"MH Alkazemi","year":"2025","unstructured":"Alkazemi MH, Alam SM, Zhang A, Pietzak EJ, Donat SM, Herr HW et al (2025) The impact of micropapillary histology and clinical staging on overall survival in bladder cancer: a retrospective analysis. J Clin Oncol 43:744","journal-title":"J Clin Oncol"},{"issue":"3","key":"5234_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.23736\/S2724-6051.23.05091-7","volume":"75","author":"G Basile","year":"2023","unstructured":"Basile G, de Angelis M, Leni R, Re C, Longoni M, Mari A et al (2023) Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review. Minerva Urol Nephrol 75(3):278\u2013288","journal-title":"Minerva Urol Nephrol"},{"issue":"8","key":"5234_CR12","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.urolonc.2012.04.009","volume":"31","author":"RB Shah","year":"2013","unstructured":"Shah RB, Montgomery JS, Montie JE, Kunju LP (2013) Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital. Urol Oncol 31(8):1650\u20131655","journal-title":"Urol Oncol"},{"issue":"5","key":"5234_CR13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.euf.2021.07.015","volume":"8","author":"C Lonati","year":"2022","unstructured":"Lonati C, Baumeister P, Afferi L, Mari A, Minervini A, Krajewski W et al (2022) Survival outcomes after immediate radical cystectomy versus conservative management with Bacillus Calmette-Gu\u00e9rin among T1 high-grade micropapillary bladder cancer patients: results from a multicentre collaboration. Eur Urol Focus 8(5):1270\u20131277","journal-title":"Eur Urol Focus"},{"issue":"5","key":"5234_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.21037\/tau-2025-80","volume":"14","author":"S Ford","year":"2025","unstructured":"Ford S, Hamilton ZA (2025) Variant histology muscle invasive bladder cancer should not preclude neoadjuvant chemotherapy before cystectomy. Transl Androl Urol 14(5):1187\u20131189","journal-title":"Transl Androl Urol"},{"issue":"11","key":"5234_CR15","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/annonc\/mdz296","volume":"30","author":"A Horwich","year":"2019","unstructured":"Horwich A, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M et al (2019) EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees\u2020. Ann Oncol 30(11):1697\u20131727","journal-title":"Ann Oncol"},{"key":"5234_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907454","volume":"12","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Xiao Y, Hu S, Wang Z, Zhu Z (2022) Neoadjuvant and adjuvant chemotherapy for variant histology bladder cancers: a systematic review and meta-analysis. Front Oncol 12:907454","journal-title":"Front Oncol"},{"issue":"1","key":"5234_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/JU.0000000000001325","volume":"205","author":"A Hajiran","year":"2021","unstructured":"Hajiran A, Azizi M, Aydin AM, Zemp L, Peyton CC, Dhillon J et al (2021) Pathological and survival outcomes associated with variant histology bladder cancers managed by cystectomy with or without neoadjuvant chemotherapy. J Urol 205(1):100\u2013108","journal-title":"J Urol"},{"issue":"2","key":"5234_CR18","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2011.e22","volume":"3","author":"NK Shapur","year":"2011","unstructured":"Shapur NK, Katz R, Pode D, Shapiro A, Yutkin V, Pizov G et al (2011) Is radical cystectomy mandatory in every patient with variant histology of bladder cancer. Rare Tumors 3(2):e22","journal-title":"Rare Tumors"},{"issue":"3","key":"5234_CR19","doi-asserted-by":"publisher","first-page":"71.e1","DOI":"10.1016\/j.urolonc.2023.12.005","volume":"42","author":"Z Lone","year":"2024","unstructured":"Lone Z, Benidir T, Wood A, Campbell RA, Alaghehbandan R, Li J et al (2024) Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histology. Urol Oncol 42(3):71.e1-.e7","journal-title":"Urol Oncol"},{"key":"5234_CR20","doi-asserted-by":"publisher","first-page":"1562260","DOI":"10.3389\/fonc.2025.1562260","volume":"15","author":"R Zhang","year":"2025","unstructured":"Zhang R, Ke CX (2025) Advances in bladder preservation therapy for muscle-invasive bladder cancer. Front Oncol 15:1562260","journal-title":"Front Oncol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05234-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05234-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05234-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:16:59Z","timestamp":1792765019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05234-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["5234"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05234-w","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective observational study. The Gold Coast Hospital and Health Service Research Ethics Committee has confirmed that no ethical approval is required (EX\/2025\/QGC\/115759).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}